A Long-term Safety & Efficacy of EnXtra (E-AG-01) in Healthy Adults

See also
Status	Clinical Trial	Phase
Completed	`NCT04560595` - Remote Guided Caffeine Reduction	N/A
Recruiting	`NCT05526170` - Triggers and Risk Factors for Recurrence of Atrial Arrhythmias With the Use of Long-term Monitoring
Completed	`NCT05323578` - Consumption Status of Caffeine and Adverse Effects Experience Among Anesthetists

See also

Status

Clinical Trial

Phase

Completed

NCT04560595 - Remote Guided Caffeine Reduction

N/A

Recruiting

NCT05526170 - Triggers and Risk Factors for Recurrence of Atrial Arrhythmias With the Use of Long-term Monitoring

Completed

NCT05323578 - Consumption Status of Caffeine and Adverse Effects Experience Among Anesthetists

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT03731286
Study type	Interventional
Source	Vedic Lifesciences Pvt. Ltd.
Contact
Status	Completed
Phase	N/A
Start date	November 23, 2018
Completion date	December 30, 2019

A Long-term Safety and Efficacy of EnXtra (E-AG-01) in Healthy Adults

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms